External validation of outcome prediction scores for aneurysmal subarachnoid hemorrhage in a real-world setting: a monocentric experience

在真实世界环境中对动脉瘤性蛛网膜下腔出血预后预测评分进行外部验证:一项单中心研究

阅读:2

Abstract

OBJECTIVE: To evaluate the applicability and performance of predictive scoring systems for outcome prediction in a real-world cohort of patients with aneurysmatic Subarachnoid Hemorrhage (aSAH), trying to avoid overtreatment and reducing their impact on Intensive Care Unit (ICU) overcrowding. METHODS: All adult patients diagnosed with aSAH from January 2018 to December 2023 were retrospectively collected in a single centre. Predictive scores such as SAFIRE, HATCH, HAIR, and Nutshell were calculated, and their performance was analyzed using receiver operating characteristic (ROC) analysis. Kaplan-Meier curves were estimated by dividing the cohort according to the calculated scores. RESULTS: Of 274 patients, 72.3% underwent endovascular treatment, 16.1% surgical clipping, and 11.7% received no treatment. The 30-day and overall mortality rates were 27.7% and 41.2%, respectively. ICU admission occurred in 74.1% of cases, with a mortality rate of 38.4%. The HAIR and the Nutshell scores performed well in predicting 30-day mortality (AUC: 0.812 and 0.749, respectively), while the SAFIRE and the HATCH scores demonstrated excellent predictive value for poor functional outcomes (AUC: 0.866 and 0.886 at discharge; 0.825 and 0.83 at one year, respectively). Patients in the worst SAFIRE group (> 15) exhibited mortality rates exceeding 89% at follow-up, with universally poor outcomes. CONCLUSION: The SAFIRE and the HATCH scores are reliable tools for predicting outcomes in aSAH patients, with SAFIRE offering particular value at admission. Their implementation in surgical practice could improve resource allocation, guide ethical decision-making, and reduce ICU burden, especially for patients with severe aSAH and limited potential for recovery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。